Nancy Ryerson

Nancy Ryerson is a digital communicator with years of experience covering healthcare. Today, she's a Digital Marketing Manager at Antidote, where she manages the company's content marketing and SEO strategies. Prior to joining Antidote, Nancy spent three years at The Michael J. Fox Foundation, where she created content for Parkinson's disease patients and expanded the Foundation's email list by 100,000+ members in two years through search and social strategies. She holds a BA in English and journalism from NYU.

Find me on:

After a Surprise Kidney Disease Diagnosis, This Patient Turned to Education and Advocacy

Patrick Gee didn't know that there were any problems with his kidneys until a doctor diagnosed him with kidney failure. Years on dialysis, four surgeries, 47 days in the hospital, and one successful kidney transplant later, he's participated in two clinical trials and become a proud advocate for the American Kidney Fund.

Continue reading

What Questions Should I Ask Before Joining a Clinical Trial?

Joining a clinical trial is a significant decision, and there are several personal factors to keep in mind when deciding whether to join – not to mention including the opinions of family members and your doctor.

Continue reading

You Searched for a Clinical Trial. Now What?

At Antidote, we talk a lot about how our search tool makes it easier to match with clinical trials you may qualify for. But what happens after you conduct your search?

Continue reading

It’s a Promising Time for Parkinson’s Disease Research – Here’s Why

It's an exciting time to consider participating in Parkinson's research, says Katie Kopil, PhD, Director of Research Partnerships at The Michael J. Fox Foundation for Parkinson's Research (MJFF).

Continue reading

How the American Kidney Fund Connects Patients with Research

Chronic kidney disease (CKD) is one of the top-ten causes of death in the United States – but 96% of people in its early stages don't even know they have it.

Continue reading

Rare Disease Day: Sometimes, Pulmonary Hypertension is the Right Diagnosis

Pulmonary hypertension (PH) is a type of high blood pressure in the lungs. A rare disease, PH is often misdiagnosed as asthma or COPD. Unfortunately, delays in diagnosis mean delays in treatment; sometimes, patients aren't diagnosed until they're in late stage disease – and by then, they have limited options.

Continue reading

New Approaches to Cardiovascular Research Aim to Connect the Lab, Pharma Industry, and Patients

Despite decades of research, heart disease continues to be the leading cause of death for both men and women in the United States. It’s clear that tackling cardiovascular disease requires a new approach. That’s why today, researchers and heart health advocates are taking on heart disease, stroke, and other conditions from a variety of angles, from exploring precision medicine to driving clinical ...

Continue reading

Rare Disease Awareness Day: Understanding the Power of Diagnosis and Connection

February 28 is Rare Disease Awareness Day. Despite the name "rare," taken together, rare diseases are actually very common – 400 million people are affected by rare diseases globally.

Continue reading

Clinical Trial Myths and Misconceptions: How to Tell Truth from Fiction

If you're considering joining a clinical trial, chances are you're also familiar with the common reasons patients choose not to participate.

Continue reading

How Backpack Health Helps Patients Organize Complex Medical Needs and Connect with Research

At Antidote, our goal is to empower patients to connect with research and seek out the best treatments while learning more about their condition. Backpack Health, our newest partner, shares our mission and gives patients a way to lighten the load of living with a chronic disease in a simple, tangible way while connecting patients with research opportunities.

Continue reading

Get our latest posts in your inbox